Annual report
7747.TEDINET S100P9GU
Period2021-07-01 → 2022-06-30
Filed2022-09-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥77.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥61.5bn | 2020-07-01 → 2021-06-30 | Cons. | Net sales |
| Revenue | ¥56.5bn | 2019-07-01 → 2020-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥57.2bn | 2018-07-01 → 2019-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥50.1bn | 2017-07-01 → 2018-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥15.2bn | 2021-07-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥12.8bn | 2020-07-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥16.3bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥13.2bn | 2020-07-01 → 2021-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥12.3bn | 2019-07-01 → 2020-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥14.8bn | 2018-07-01 → 2019-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.7bn | 2017-07-01 → 2018-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥15.7bn | 2021-07-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥13.1bn | 2020-07-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥10.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.0bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.2bn | 2019-07-01 → 2020-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.2bn | 2018-07-01 → 2019-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥10.0bn | 2017-07-01 → 2018-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥11.0bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥10.0bn | 2020-07-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥155.1bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥115.4bn | at 2021-06-30 | Cons. | Assets |
| Total assets | ¥93.7bn | at 2020-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥84.4bn | at 2019-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥72.1bn | at 2018-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥34.0bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥22.5bn | at 2021-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥121.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥92.9bn | at 2021-06-30 | Cons. | Net assets |
| Net assets / equity | ¥72.0bn | at 2020-06-30d | Cons. | Net assets |
| Net assets / equity | ¥65.5bn | at 2019-06-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥53.6bn | at 2018-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥32.3bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥21.4bn | at 2021-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥32.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.4bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.6bn | at 2020-06-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.8bn | at 2019-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥17.5bn | at 2018-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥17.3bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥8.9bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥11.2bn | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥11.7bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥11.7bn | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥18.7bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥16.3bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.4bn | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.8bn | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.5bn | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥11.4bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥10.1bn | 2020-07-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥850m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥267m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.7bn | 2017-07-01 → 2018-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥40.01 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.25 | 2020-07-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.25 | 2019-07-01 → 2020-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.29 | 2018-07-01 → 2019-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.88 | 2017-07-01 → 2018-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥40 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥38.07 | 2020-07-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥35.07 | 2019-07-01 → 2020-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.02 | 2018-07-01 → 2019-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥38.63 | 2017-07-01 → 2018-06-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥439.8 | at 2022-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥349.18 | at 2021-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥276.13 | at 2020-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥251.37 | at 2019-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥207.34 | at 2018-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 77.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.5% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.8% | at 2020-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.6% | at 2019-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.3% | at 2018-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 10.2% | 2021-07-01 → 2022-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2020-07-01 → 2021-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.4% | 2019-07-01 → 2020-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.9% | 2018-07-01 → 2019-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 20.4% | 2017-07-01 → 2018-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 10,435 | at 2022-06-30 | Cons. | Number of employees |
| Employees | 9,409 | at 2021-06-30 | Cons. | Number of employees |
| Employees | 8,761 | at 2020-06-30d | Cons. | Number of employees |
| Employees | 7,810 | at 2019-06-30d | Cons. | Number of employees |
| Employees | 6,998 | at 2018-06-30d | Cons. | Number of employees |
| Revenue | ¥63.5bn | 2021-07-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥50.9bn | 2020-07-01 → 2021-06-30 | Standalone | Net sales |
| Revenue | ¥47.4bn | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥46.1bn | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥40.4bn | 2017-07-01 → 2018-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥11.0bn | 2021-07-01 → 2022-06-30 | Standalone | Operating income |
| Operating income | ¥8.2bn | 2020-07-01 → 2021-06-30 | Standalone | Operating income |
| Ordinary income | ¥13.2bn | 2021-07-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥8.9bn | 2020-07-01 → 2021-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥10.0bn | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.9bn | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.2bn | 2017-07-01 → 2018-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥12.8bn | 2021-07-01 → 2022-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥8.8bn | 2020-07-01 → 2021-06-30 | Standalone | Income before income taxes |
| Net income | ¥9.5bn | 2021-07-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥6.7bn | 2020-07-01 → 2021-06-30 | Standalone | Profit loss |
| Net income | ¥7.9bn | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.9bn | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.3bn | 2017-07-01 → 2018-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥120.9bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥91.4bn | at 2021-06-30 | Standalone | Assets |
| Total assets | ¥71.3bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥60.9bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥53.5bn | at 2018-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥34.7bn | at 2022-06-30 | Standalone | Liabilities |
| Total liabilities | ¥24.2bn | at 2021-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥86.2bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥67.2bn | at 2021-06-30 | Standalone | Net assets |
| Net assets / equity | ¥49.6bn | at 2020-06-30d | Standalone | Net assets |
| Net assets / equity | ¥44.1bn | at 2019-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥36.2bn | at 2018-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥23.0bn | at 2022-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥8.3bn | at 2021-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥35.09 | 2021-07-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.8 | 2020-07-01 → 2021-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.32 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.51 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.32 | 2017-07-01 → 2018-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥35.08 | 2021-07-01 → 2022-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.68 | 2020-07-01 → 2021-06-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.16 | 2019-07-01 → 2020-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.32 | 2018-07-01 → 2019-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.13 | 2017-07-01 → 2018-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥11.99 | 2021-07-01 → 2022-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥11.26 | 2020-07-01 → 2021-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥8.81 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥21.61 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19.43 | 2017-07-01 → 2018-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥317.39 | at 2022-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥252.48 | at 2021-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥190.43 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥169.61 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥139.91 | at 2018-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 71.3% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.4% | at 2021-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.6% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.5% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.5% | at 2018-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.4% | 2021-07-01 → 2022-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.5% | 2020-07-01 → 2021-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.8% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.7% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.1% | 2017-07-01 → 2018-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 271,633,600 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 265,972,800 | at 2021-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 260,561,600 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 130,134,000 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 129,241,600 | at 2018-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,041 | at 2022-06-30 | Standalone | Number of employees |
| Employees | 925 | at 2021-06-30 | Standalone | Number of employees |
| Employees | 875 | at 2020-06-30d | Standalone | Number of employees |
| Employees | 755 | at 2019-06-30d | Standalone | Number of employees |
| Employees | 666 | at 2018-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 57
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-07-01 → 2022-06-30 | ¥261m |
| Reconciling Itemsreconciling | depreciation | 2021-07-01 → 2022-06-30 | ¥280m |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-06-30 | −¥13.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-06-30 | −¥13.9bn |
| Reconciling Itemsreconciling | segment assets | at 2022-06-30 | ¥17.1bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-06-30 | −¥4.1bn |
| Devicereportable segment | capex | 2021-07-01 → 2022-06-30 | ¥3.0bn |
| Devicereportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥2.4bn |
| Devicereportable segment | employees | at 2022-06-30 | 3400 pure |
| Devicereportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥23.3bn |
| Devicereportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥9.4bn |
| Devicereportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥13.9bn |
| Devicereportable segment | segment assets | at 2022-06-30 | ¥33.5bn |
| Devicereportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥5.3bn |
| Medicalreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥5.7bn |
| Medicalreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥3.7bn |
| Medicalreportable segment | employees | at 2022-06-30 | 6482 pure |
| Medicalreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥68.3bn |
| Medicalreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥68.3bn |
| Medicalreportable segment | segment assets | at 2022-06-30 | ¥104.5bn |
| Medicalreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥14.1bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-07-01 → 2022-06-30 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-07-01 → 2022-06-30 | ¥6.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-06-30 | ¥91.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-06-30 | ¥77.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-06-30 | ¥138.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-06-30 | ¥19.4bn |
| Reconciling Itemsreconciling | capex | 2020-07-01 → 2021-06-30 | ¥1.6bn |
| Reconciling Itemsreconciling | depreciation | 2020-07-01 → 2021-06-30 | ¥346m |
| Reconciling Itemsreconciling | revenue | 2020-07-01 → 2021-06-30 | −¥5.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2020-07-01 → 2021-06-30 | −¥5.9bn |
| Reconciling Itemsreconciling | segment assets | at 2021-06-30 | ¥15.8bn |
| Reconciling Itemsreconciling | segment profit | 2020-07-01 → 2021-06-30 | −¥4.3bn |
| Devicereportable segment | capex | 2020-07-01 → 2021-06-30 | ¥6.0bn |
| Devicereportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥1.3bn |
| Devicereportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥14.1bn |
| Devicereportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥8.4bn |
| Devicereportable segment | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥5.7bn |
| Devicereportable segment | segment assets | at 2021-06-30 | ¥23.6bn |
| Devicereportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥3.3bn |
| Medicalreportable segment | capex | 2020-07-01 → 2021-06-30 | ¥4.1bn |
| Medicalreportable segment | depreciation | 2020-07-01 → 2021-06-30 | ¥3.1bn |
| Medicalreportable segment | revenue | 2020-07-01 → 2021-06-30 | ¥53.3bn |
| Medicalreportable segment | revenue external | 2020-07-01 → 2021-06-30 | ¥53.1bn |
| Medicalreportable segment | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥249m |
| Medicalreportable segment | segment assets | at 2021-06-30 | ¥76.0bn |
| Medicalreportable segment | segment profit | 2020-07-01 → 2021-06-30 | ¥13.7bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-07-01 → 2021-06-30 | ¥10.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-07-01 → 2021-06-30 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-07-01 → 2021-06-30 | ¥67.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-07-01 → 2021-06-30 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-07-01 → 2021-06-30 | ¥5.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-06-30 | ¥99.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-07-01 → 2021-06-30 | ¥17.0bn |
| Devicereportable segment | employees | at 2022-06-30 | 285 pure |
| Medicalreportable segment | employees | at 2022-06-30 | 639 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,525
| Item | Context | Value | Unit |
|---|---|---|---|
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 2804000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 10962000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 18554000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 21358000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 21358000000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 32321000000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 18 | |
| Notes receivable trade | CurrentYearInstant | 378000000 | JPY |
| Accounts receivable trade | CurrentYearInstant | 13608000000 | JPY |
| Write downs of inventories | Prior1YearDuration | 80000000 | JPY |
| Write downs of inventories | CurrentYearDuration | 31000000 | JPY |
| Research and development expenses sga | Prior1YearDuration | 7524000000 | JPY |
| Research and development expenses sga | CurrentYearDuration | 8869000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 53068000000 | JPY |
| Revenues from external customers | Prior1YearDuration_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 8438000000 | JPY |
| Revenues from external customers | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 61507000000 | JPY |
| Revenues from external customers | Prior1YearDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YearDuration | 61507000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 249000000 | JPY |
| Transactions with other segments | Prior1YearDuration_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 5665000000 | JPY |
| Transactions with other segments | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 5915000000 | JPY |
| Transactions with other segments | Prior1YearDuration_ReconcilingItemsMember | -5915000000 | JPY |
| Transactions with other segments | Prior1YearDuration | － | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 53317000000 | JPY |
| Net sales | Prior1YearDuration_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 14104000000 | JPY |
| Net sales | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 67422000000 | JPY |
| Net sales | Prior1YearDuration_ReconcilingItemsMember | -5915000000 | JPY |
| Net sales | Prior1YearDuration | 61507000000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 13700000000 | JPY |
| Operating income | Prior1YearDuration_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 3349000000 | JPY |
| Operating income | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 17049000000 | JPY |
| Operating income | Prior1YearDuration_ReconcilingItemsMember | -4254000000 | JPY |
| Operating income | Prior1YearDuration | 12795000000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 76018000000 | JPY |
| Assets | Prior1YearInstant_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 23643000000 | JPY |
| Assets | Prior1YearInstant_TotalOfReportableSegmentsAndOthersMember | 99662000000 | JPY |
| Assets | Prior1YearInstant_ReconcilingItemsMember | 15764000000 | JPY |
| Assets | Prior1YearInstant | 115427000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 3129000000 | JPY |
| Depreciation segment information | Prior1YearDuration_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 1342000000 | JPY |
| Depreciation segment information | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 4472000000 | JPY |
| Depreciation segment information | Prior1YearDuration_ReconcilingItemsMember | 346000000 | JPY |
| Depreciation segment information | Prior1YearDuration | 4819000000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 4099000000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 6015000000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_TotalOfReportableSegmentsAndOthersMember | 10114000000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration_ReconcilingItemsMember | 1649000000 | JPY |
| Increase in property plant and equipment and intangible assets | Prior1YearDuration | 11764000000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E02349-000MedicalReportableSegmentsMember | 68345000000 | JPY |
| Revenues from external customers | CurrentYearDuration_jpcrp030000-asr_E02349-000DeviceReportableSegmentsMember | 9403000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |